Atenolol Market Players:
- Intas Pharmaceuticals Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Zydus Pharmaceuticals (USA) Inc.
- Ipca Laboratories Limited
- Unichem Laboratories Limited
- AstraZeneca PLC
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of atenolol is estimated at USD 13.92 billion.
The global atenolol market size was around USD 13 billion in 2025 and is likely to expand at a CAGR of more than 7.9%, surpassing USD 27.81 billion revenue by 2035.
North America in the atenolol market is anticipated to command a 40% revenue share by 2035, attributed to the escalating prevalence of cardiac diseases and hypertension across the region.
Key players in the market include Infineon Technologies AG, NXP Semiconductors N.V., Robert Bosch GmbH, Analog Devices, Inc., Micron Technology, Inc., Semiconductor Components Industries, LLC, Renesas Electronics Corporation, Rohm Co., Ltd., STMicroelectronics International N.V., Texas Instruments Incorporated.
